Phospholipase A2

From Wikipedia, the free encyclopedia

Bee venom phospholipase A2 sPLA2. Middle plane of the lipid bilayer - black dots. Boundary of the hydrocarbon core region - red dots (extracellular side). Layer of lipid phosphates - yellow dots.
Bee venom phospholipase A2 sPLA2. Middle plane of the lipid bilayer - black dots. Boundary of the hydrocarbon core region - red dots (extracellular side). Layer of lipid phosphates - yellow dots.
Phospholipase Cleavage Sites.  Note that an enzyme that displays both PLA1 and PLA2 activities is called a Phospholipase B
Phospholipase Cleavage Sites. Note that an enzyme that displays both PLA1 and PLA2 activities is called a Phospholipase B

Phospholipases A2 (PLA2s) EC 3.1.1.4 are upstream regulators of many inflammatory processes. This particular phospholipase specifically recognizes the sn-2 acyl bond of phospholipids and catalytically hydrolyzes the bond releasing arachidonic acid and lysophospholipids. Upon downstream modification by cyclooxygenases, arachidonic acid is modified into active compounds called eicosanoids. Eicosanoids include prostaglandins and leukotrienes which are categorized as inflammatory mediators.[1]

PLA2 are commonly found in mammalian tissues as well as insect and snake venom.[2] Venom from both snakes and insects is largely composed of melittin which is a stimulant of PLA2. Due to the increased presence and activity of PLA2 resulting from a snake or insect bite, arachidonic acid is released from the phospholipid membrane disproportionately. As a result, inflammation and pain occur at the site.[3] There are also prokaryotic A2 phospholipases.

Additional types of phospholipases include phospholipase A1, phospholipase B, phospholipase C, and phospholipase D.[4]

Contents

[edit] Families

Phospholipases A2 include several unrelated protein families with common enzymatic activity. Two most notable families are secreted and cytosolic phospholipases A2. Other families include Ca2+ independent PLA2 (iPLA2) and lipoprotein-associated PLA2s (lp-PLA2), also known as platelet activating factor acetylhydrolase (PAF-AH).

[edit] Secreted phospholipases A2 (sPLA2)

The extracellular forms of phospholipases A2 have been isolated from different venoms (snake, bee, and wasp), from virtually every studied mammalian tissue (including pancreas and kidney) as well as from bacteria. They require Ca2+ for activity.

Pancreatic PLA2 serve for the initial digestion of phospholipid compounds in dietary fat. Venom phospholipases help to immobilize prey by promoting cell lysis.

[edit] Cytosolic phospholipases A2 (cPLA2)

The intracellular PLA2 are also Ca-dependent, but they have completely different 3D structure and significantly larger than secreted PLA2 (more than 700 residues). They include C2 domain and large catalytic domain.

These phospholipases are involved in cell signaling processes, such as inflammatory response. The produced Arachidonic acid is both a signaling molecule and the precursor for other signalling molecules termed eicosanoids. These include leukotrienes and prostaglandins. Some eicosanoids are synthesized from diacylglycerol, released from the lipid bilayer by phospholipase C (see below).

Phospholipases A2 can be classified based on sequence homology.[5]

[edit] Mechanism

Close-up rendering of PLA2 active site with phosphate enzyme inhibitor.  Calcium ion (pink) coordinates with phosphate (light blue).  Phosphate mimics tetrahedral intermediate blocking substrate access to active site.  His-48, Asp-99, and 2 water molecules are also shown.     [1]From PDB 1FXF.
Close-up rendering of PLA2 active site with phosphate enzyme inhibitor. Calcium ion (pink) coordinates with phosphate (light blue). Phosphate mimics tetrahedral intermediate blocking substrate access to active site. His-48, Asp-99, and 2 water molecules are also shown. [6] [1]From PDB 1FXF.

The suggested catalytic mechanism of pancreatic sPLA2 is initiated by a His-48/Asp-99/calcium complex within the active site. The calcium ion polarizes the sn-2 carbonyl oxygen while also coordinating with a catalytic water molecule, w5. His-48 improves the nucleophilicity of the catalytic water via a bridging second water molecule, w6. It has been suggested that two water molecules are necessary to traverse the distance between the catalytic histidine and the ester. The basicity of His-48 is thought to be enhanced through hydrogen bonding with Asp-99. An asparagine substitution for His-48 maintains wild-type activity, as the amide functional group on asparagine can also function to lower the pKa, or acid dissociation constant, of the bridging water molecule. The rate limiting state is characterized as the degradation of the tetrahedral intermediate composed of a calcium coordinated oxyanion. The role of calcium can also be duplicated by other relatively small cations like colbalt and nickel. [7]

Image:chem draw.png

PLA2 can also be characterized as having a channel featuring a hydrophobic wall in which hydrophobic amino acid residues such as Phe, Leu, and Tyr serve to bind the substrate. Another component of PLA2 is the seven disulfide bridges which are influential in regulation and stable protein folding.[8]

Phospholipase A2
Identifiers
Symbol Phospholip_A2_1
Pfam PF00068
InterPro IPR001211
PROSITE PDOC00109
SCOP 1bbc
OPM family 90
OPM protein 1g4i
Available PDB structures:

1vkqA:23-145 1mks :23-145 1gh4A:23-145 4bp2 :23-145 1kvw :23-145 1irb :23-145 1kvx :23-145 1o2eA:23-145 2bpp :23-145 1une :23-145 1vl9A:23-145 1g4iA:23-145 1bvmA:23-145 1o3wA:23-145 2bp2 :23-145 1mkv :23-145 1ceh :23-145 1bpq :23-145 1mku :23-145 1bp2 :23-145 1c74A:23-145 3bp2 :24-145 1kvy :23-145 1fdk :23-145 1mkt :23-145 2baxA:23-145 1y6oA:23-146 2phiA:23-146 1hn4A:23-146 1y6pA:23-146 1fxfB:23-146 1fx9B:23-146 1l8sB:23-146 1pis :23-146 1sfw :23-146 1sfv :23-146 1pir :23-146 3p2pB:23-146 5p2pB:23-146 4p2p :23-146 1p2p :23-146 1m8tD:28-146 1gp7B:28-151 1pobA:28-145 1poa :28-145 1pshA:1-118 1owsB:4-118 1a3fC:1-118 1a3d :1-118 1sz8A:8-125 1ln8A:8-125 1yxlA:8-125 1t37A:8-125 1mf4A:8-125 1zm6A:8-125 1oxrA:8-125 1td7A:9-125 1mh2B:8-125 1xxwB:8-125 1s6bB:8-125 1yxhA:8-125 1y75A:8-124 1mh8A:8-125 1mh7A:8-125 1oo1A:1-117 1g2xA:28-141 1fe5A:28-144 1dpyA:28-144 1po8A:34-132 1u4jA:20-136 1tc8A:20-136 1ae7N:1-118 2notA:1-118 1lx1A:1-118 1bunA:28-146 1vipP:1-121 1oz6A:17-136 1q5tB:1-122 1aokA:1-122 1jltA:1-122 1vpi :1-122 1oqsA:17-138 1rgbA:1-122 1pp2L:17-138 1ijlA:1-123 1m8rA:1-124 1bk9 :1-124 1psj :1-124 1m8sA:1-124 1vapA:1-123 1u73B:17-138 1umvX:17-138 1pa0B:1-119 1pc9B:1-119 1qllA:1-121 1xxsB:1-122 1clpB:1-121 1y4lA:1-121 1godA:1-121 1s8iA:17-137 1s8hA:17-137 1s8gA:17-137 1ppa :1-121 1mc2A:17-138 1mg6A:17-138 1gmzB:1-106 1bjjF:1-122 1a2aF:1-122 1c1jC:1-122 1jiaB:18-138 1b4wC:18-138 1y38A:1-121 1cl5B:1-121 1jq9A:1-121 2fnxA:1-121 1tg1A:1-121 1fv0A:1-121 1tj9A:1-121 1tjqA:1-121 1sxkA:1-121 1tp2B:1-121 1zyxA:1-121 1tdvA:1-121 1jq8B:1-121 1tgmA:1-121 2b17A:1-121 1oxlB:1-121 1sv3A:1-121 1oyfA:1-121 1tk4A:1-121 1th6A:1-121 1kpmA:1-121 2armA:1-121 1sqzA:1-121 1fb2B:1-121 1ti0A:1-121 1q7aA:1-121 1tg4A:1-121 1sv9A:1-121 1q6vA:1-121 1zr8A:1-121 1tjkA:1-121 1kvoA:21-144 1aypD:21-144 1n28A:22-144 1dcyA:21-144 1n29A:22-144 1db4A:21-144 1j1aB:21-144 1bbc :21-144 1pod :21-144 1poeB:21-144 1kquA:21-144 1db5A:21-144 1le7A:33-154 1le6B:33-154

[edit] Regulation

Due to the importance of PLA2 in inflammatory responses, regulation of the enzyme is essential. PLA2 is regulated by phosphorylation and calcium concentrations. PLA2 is phosphorylated by a MAPK at Serine-505. When phosphorylation is coupled with an influx of calcium ions, PLA2 becomes stimulated and can translocate to the membrane to begin catalysis. [9]

[edit] Relevance in Neurological Disorders

In normal brain cells, PLA2 regulation accounts for a balance between arachidonic acid conversion into proinflammatory mediators and arachidonic acid reincorporation into the membrane. In the absence of strict regulation of PLA2 activity, a disproportionate amount of proinflammatory mediators are produced. The resulting induced oxidative stress and neuroinflammation is analogous to neurological diseases such as Alzheimer’s disease, epilepsy, multiple sclerosis, ischemia. Lysophospholipids are another class of molecules released from the membrane that are upstream predecessors of platelet activating factors (PAF). Abnormal levels of potent PAF are also associated with neurological damage. An optimal enzyme inhibitor would specifically target PLA2 activity on neural cell membranes already under oxidative stress and potent inflammation. Thus, specific inhibitors of brain PLA2 could be a pharmaceutical approach to treatment of several disorders associated with neural trauma.[10]

Increased phospholipase 2A has also been associated with neuropsychiatric disorders such as schizophrenia and pervasive developmental disorders (such as autism), though the mechanisms involved are not known.[11]

[edit] Human proteins containing phospholipase A2 domain

OC90; PLA2G10; PLA2G1B; PLA2G2A; PLA2G2D; PLA2G2E; PLA2G2F; PLA2G3; PLA2G5;

[edit] References

  1. ^ Dennis, et al. "Diversity of Group Types, Regulation, and Function of Phospholipase A2." The Journal of Biological Chemistry. VOl. 269. No 18. 13057-13060.
  2. ^ Nicholas, et al. "Localization of Structural Elements of Bee Venom Phospholipase A2 Involved in N-type Receptor Binding and Neurotoxicity." Journal of Biological Chemistry. Vol. 227. No. 11. 7173-7181.
  3. ^ Argiolas, Pianso. "Facilitation of Phospholipase A2 Activity by Mastoparans, a New Class of Mast Cell Degranulating Peptides from Wasp Venom." Journal of Biological Chemistry. Vol. 285. Issue 122. 13697-13702
  4. ^ Lehninger. "Principles of Biochemistry". 2004. W H Freeman and Company. Fourth Edition.
  5. ^ Six DA, Dennis EA (2000). "The expanding superfamily of phospholipase A(2) enzymes: classification and characterization". Biochim. Biophys. Acta 1488 (1-2): 1-19. PMID 11080672. 
  6. ^ Pan, Y.H., Epstein, T.M., Jain, M.K., Bahnson, B.J. (2001) Five coplanar anion binding sites on one face of phospholipase A2: relationship to interface binding. Biochemistry 40: 609-617
  7. ^ Berg et al. “Interfacial Enzymology: The Secreted Phospholipase A2-Paradigm” Chemical Review, 2001. Vol. 101. No. 9 2638-2640.
  8. ^ Berg et al. “Interfacial Enzymology: The Secreted Phospholipase A2-Paradigm” Chemical Review, 2001. Vol. 101. No. 9 2638-2640.
  9. ^ Leslie et al. “Properties and Regulation of Cytosolic Phospholipase A2”. 1997. The Journal of Biochemistry. Vol. 272. No. 27. 16709-16712.
  10. ^ Farooqui et al. “Inhibitors of Brain Phospholipase A2 Activity: Their Neuropharmacological Effects and Therapeutic Importance for the Treatment of Neurologic Disorders” 2006. Pharmacological Reviews. Vol. 58. 591-620.
  11. ^ Bell, JG et al.. Essential fatty acids and phospholipase A2 in autistic spectrum disorders. 2004. Prostaglandins, Leukotrienes and Essential Fatty Acids. Vol. 71. 201-204

[edit] Genes

[edit] External links